Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin L Robb

Showing results (151-160 of 358) with videos related to

Pageof 36
Sort By:
Virology|August 26, 2020
Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in ThailandLindsay Wieczorek, Kristina Peachman, Daniel J Adams, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2009
Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infectionMichael A Eller, Leigh Anne Eller, Benson J Ouma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2016
Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV InfectionIrini Sereti, Shelly J Krebs, Nittaya Phanuphak, et al.
Plos One|October 11, 2012
Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimensSilvia Ratto-Kim, Jeffrey R Currier, Josephine H Cox, et al.
Nature Communications|December 22, 2018
Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapyJames B Whitney, So-Yon Lim, Christa E Osuna, et al.
Journal of Virology|November 20, 2015
Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral ReservoirsDiane L Bolton, Amarendra Pegu, Keyun Wang, et al.
Eclinicalmedicine|September 10, 2021
Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, ThailandTanyaporn Wansom, Sant Muangnoicharoen, Sorachai Nitayaphan, et al.
Elife|April 15, 2024
A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1Swati Jain, Gherman Uritskiy, Marthandan Mahalingam, et al.
AIDS Research and Human Retroviruses|October 31, 2003
Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1Jerome H Kim, Punnee Pitisuttithum, Chirasak Kamboonruang, et al.
Journal of Virology|May 15, 2015
Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV ViremiaSusan Johnson, Michael Eller, Jeffrey E Teigler, et al.
Pageof 36

Showing results (151-160 of 358) with videos related to

Sort By:
Pageof 36
Virology|August 26, 2020
Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in ThailandLindsay Wieczorek, Kristina Peachman, Daniel J Adams, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2009
Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infectionMichael A Eller, Leigh Anne Eller, Benson J Ouma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2016
Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV InfectionIrini Sereti, Shelly J Krebs, Nittaya Phanuphak, et al.
Plos One|October 11, 2012
Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimensSilvia Ratto-Kim, Jeffrey R Currier, Josephine H Cox, et al.
Nature Communications|December 22, 2018
Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapyJames B Whitney, So-Yon Lim, Christa E Osuna, et al.
Journal of Virology|November 20, 2015
Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral ReservoirsDiane L Bolton, Amarendra Pegu, Keyun Wang, et al.
Eclinicalmedicine|September 10, 2021
Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, ThailandTanyaporn Wansom, Sant Muangnoicharoen, Sorachai Nitayaphan, et al.
Elife|April 15, 2024
A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1Swati Jain, Gherman Uritskiy, Marthandan Mahalingam, et al.
AIDS Research and Human Retroviruses|October 31, 2003
Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1Jerome H Kim, Punnee Pitisuttithum, Chirasak Kamboonruang, et al.
Journal of Virology|May 15, 2015
Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV ViremiaSusan Johnson, Michael Eller, Jeffrey E Teigler, et al.
Pageof 36